Unresolved issues of anticoagulation in atrial fibrillation: age, BMI, reduced dose, and ethnicity

被引：3
|
作者：
Luscher, Thomas F. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Imperial Coll, Cardiol, London, England
[2] Royal Brompton Hosp, Res Educ & Dev, London, England
[3] Harefield Hosp London, London, England
[4] Univ Zurich, Ctr Mol Cardiol, Zurich, Switzerland
[5] Zurich Heart House, EHJ Editorial Off, Hottingerst 14, CH-8032 Zurich, Switzerland
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷 / 19期
关键词：
ORAL ANTICOAGULANTS; MANAGEMENT; STROKE; EVENTS;
D O I：
10.1093/eurheartj/ehz302
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1477 / 1481
页数：5
相关论文
共 33 条
  • [1] Atrial Fibrillation and Anticoagulation in Old Age
    Darius, Harald
    AKTUELLE KARDIOLOGIE, 2020, 9 (05) : 440 - 446
  • [2] Atrial cardiomyopathy: Diagnosis, clinical implications and unresolved issues in anticoagulation therapy
    Kariki, Ourania
    Vlachos, Konstantinos
    Dragasis, Stylianos
    Tsetika, Eleftheria-Garyfalia
    Perlepe, Kalliopi
    Saplaouras, Athanasios
    Nyktari, Eva
    Efremidis, Michael
    Letsas, Konstantinos P.
    JOURNAL OF ELECTROCARDIOLOGY, 2023, 76 : 1 - 10
  • [3] Managing anticoagulation for atrial fibrillation: current issues and future strategies
    Camm, A. John
    JOURNAL OF INTERNAL MEDICINE, 2013, 273 (01) : 31 - 41
  • [4] Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation Findings From the Get With The Guidelines-Atrial Fibrillation Registry
    Essien, Utibe R.
    Chiswell, Karen
    Kaltenbach, Lisa A.
    Wang, Tracy Y.
    Fonarow, Gregg C.
    Thomas, Kevin L.
    Turakhia, Mintu P.
    Benjamin, Emelia J.
    Rodriguez, Fatima
    Fang, Margaret C.
    Magnani, Jared W.
    Yancy, Clyde W.
    Piccini, Jonathan P., Sr.
    JAMA CARDIOLOGY, 2022, 7 (12) : 1207 - 1217
  • [5] Optimal anticoagulation in elderly patients with atrial fibrillation: Which drug at which dose?
    Liao, Jo-Nan
    Chan, Yi-Hsin
    Kuo, Ling
    Tsai, Chuan-Tsai
    Lim, Su-Shen
    Chao, Tze-Fan
    KARDIOLOGIA POLSKA, 2022, 80 (02) : 128 - 136
  • [6] From Guidelines to Bench: Implications of Unresolved Clinical Issues for Basic Investigations of Atrial Fibrillation Mechanisms
    Nattel, Stanley
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (01) : 19 - 26
  • [7] Relationships, Current Issues, Safety and Efficacy of Oral Anticoagulation in Cancer Patients with Atrial Fibrillation
    Franchina, Antonio Gabriele
    Rocchetti, Matteo
    Sala, Elena
    Laricchia, Alessandra
    Minardi, Alessandro
    Spangaro, Andrea
    Guazzi, Marco
    Lucreziotti, Stefano
    Cereda, Alberto
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [8] Age threshold for anticoagulation in patients with atrial fibrillation: A Swedish nationwide observational study
    Andersson, Tommy
    Aspberg, Sara
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 326 : 92 - 97
  • [9] Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation
    Inohara, Taku
    Holmes, DaJuanicia N.
    Pieper, Karen
    Blanco, Rosalia G.
    Allen, Larry A.
    Fonarow, Gregg C.
    Gersh, Bernard J.
    Hylek, Elaine M.
    Ezekowitz, Michael D.
    Kowey, Peter R.
    Reiffel, James A.
    Naccarelli, Gerald V.
    Chan, Paul S.
    Mahaffey, Kenneth W.
    Singer, Daniel E.
    Freeman, James V.
    Steinberg, Benjamin A.
    Peterson, Eric D.
    Piccini, Jonathan P.
    HEART, 2020, 106 (05) : 358 - 364
  • [10] Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
    Fauchier, Laurent
    Blin, Patrick
    Sacher, Frederic
    Dureau-Pournin, Caroline
    Bernard, Marie-Agnes
    Lassalle, Regis
    Droz-Perroteau, Cecile
    Dallongeville, Jean
    Moore, Nicholas
    EUROPACE, 2020, 22 (02): : 205 - 215
1234